AMDI Fast PCR device in clinical setting

Clinical, Operational, and Economic Confidence Without Compromise

AMDI Fast PCR is designed to remove the usual tradeoff between speed and confidence by delivering RT-PCR respiratory results in a time frame that still fits real-time care. The point is not speed by itself; it’s getting a molecular result that clinicians can use while the patient is still present. That is what makes the result clinically useful and AMDI Fast PCR relevant at the Time of Care™.

Built for the Moment When a Respiratory Result Can Still Shape Care

By bringing molecular testing into the actual visit, clinicians can receive a respiratory result, all while clinical assessment, treatment planning, patient counseling and documentation are still happening. The AMDI Fast PCR Mini Respiratory Panel detects and differentiates SARS-CoV-2, influenza A, influenza B, and RSV nucleic acids from anterior nasal swab specimens in symptomatic patients.

Respiratory virus particle

Symptoms Overlap. Clinical Decisions Cannot Wait.

Flu A, Flu B, RSV, and SARS-CoV-2 can present with similar symptoms, especially at the point of care, where time is limited and decisions need to be made quickly. AMDI Fast PCR is designed to help clinicians move beyond symptom overlap with a multiplex RT-PCR result that arrives when the patient is still at the visit, not after.

This is TIME OF CARE™: When the question is still clinically viable and the answer is fast and credible.

Clinical Support From Real Point-of-Care Study Work

Our clinical support is built around multicenter respiratory study work in decentralized care settings. The AMDI Clinical program for the Mini Respiratory Panel clinical study enrolled more than 1,900 subjects to evaluate Flu A, Flu B, RSV, and SARS-CoV-2. This matters because a same-visit result must be more than fast; it must be strong enough to inform clinical action.

1,900+ subjects

4 respiratory targets

Point-of-care relevance

Review Clinical Data

Help Close the Visit With Fewer Loose Ends

When the respiratory result is available during the encounter, the visit is easier to complete in one flow. The team can review findings, discuss next steps, document the plan, and move forward without waiting for the answer to catch up later. The system is designed to support a more complete visit and reduce the operational and financial burden that comes from unresolved follow-up work.

This is TIME OF CARE™: Reducing downstream workload by delivering a result while the visit is still active and the team can address the next step in real time.

Operational Efficiency Is Financial Efficiency

Financial performance and operational performance are tied together. When the team spends less time on callbacks, rework, and delayed result management, the site can use staffing more effectively and keep care moving with less friction. AMDI Fast PCR is designed to support that alignment by delivering RT-PCR respiratory results at the Time of Care™, when both clinical and operational values are highest.

This is TIME OF CARE™: Keeping the visit intact instead of pushing the result into rework later.

Protect Staff Time From Avoidable Follow-Up

Staff time is one of the most expensive resources in front-line care. The system is designed to help protect that time by reducing the need for result-related callbacks, duplicated communication, and fragmented follow-up tasks that pull teams away from active patients. When the respiratory result arrives during the visit, the team can use their time more effectively and keep work concentrated in the original encounter.

Scalability

Stack up to four modules to run up to four tests at the same time.

Less Duplicated Communication

Fewer repeated explanations across separate touchpoints.

More efficient visit completion

More of the work gets done while the patient is still present.

AMDI Fast PCR device stack with tablet

Built for More Than a Fast Result

AMDI Fast PCR supports a broader value model around respiratory testing by design. The platform is intended to help sites reduce hidden workflow costs, limit avoidable staff effort, and bring more of the testing value into the original encounter. That makes the result more useful, the workflow more efficient, and the overall testing model more sustainable. The modular design allows sites to stack up to four instruments, supporting up to four simultaneous tests as respiratory demand changes.

Testing Works Better When Results Move Cleanly

Operational efficiency is not only about runtime, it is also about what happens after the result is generated. By fitting into a broader connected workflow, AMDI Fast PCR helps to support cleaner result handling, better information flow, and a more usable testing process from instrument to next step. The goal is not just a fast answer. The goal is an answer that moves through operations without creating more work.

Centralized oversight

Built for connectivity from the onset, the cloud-based workflow seamlessly integrates into existing systems so your practice has more time for patient interactions

Results access

System receives results immediately after they are generated, helping to reduce manual entry errors

Fleet and device management

No matter the size of your practice, cloud connectivity allows for flexibility

Multi-site visibility

When results are ready, they become accessible across your practice ecosystem instantly

This is TIME OF CARE™: When speed and clinical confidence come together, not compete.

One Anterior Nasal Swab. One RT-PCR Respiratory Panel. One Patient Visit.

Four respiratory targets: Flu A, Flu B, RSV, and SARS-CoV-2.

AMDI Fast PCR pairs a familiar anterior nasal swab with a focused four-target respiratory RT-PCR panel designed for same-visit use. The workflow stays simple because the clinical value is already clear: a molecular respiratory result delivered in time to matter. Intended for individuals with signs and symptoms of respiratory tract infection.

Current Panel Available

The system is compatible with anterior nasal swab specimens and covers the following:

  • Influenza A
  • Influenza B
  • Respiratory Syncytial Virus (RSV)
  • SARS-CoV-2

The panel will continue to expand to keep up with ongoing and evolving diagnostic needs.

Future Panels in the Pipeline

As your practice evolves, so do your needs. Our panel will continue to update and expand. Stay tuned for additional developments.

Review more details about the analytical sensitivity of AMDI Fast PCR

AMDI Fast PCR device